PDB Short entry for 1OHE HEADER HYDROLASE 24-MAY-03 1OHE TITLE STRUCTURE OF CDC14B PHOSPHATASE WITH A PEPTIDE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CDC14B2 PHOSPHATASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CORE DOMAIN, RESIDUES 39-386; COMPND 5 SYNONYM: CDC14B; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE LIGAND; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: SUBSTRATE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 12 ORGANISM_TAXID: 562 KEYWDS PROTEIN PHOSPHATASE, CELL CYCLE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.H.GRAY,V.M.GOOD,N.K.TONKS,D.BARFORD REVDAT 3 08-MAY-19 1OHE 1 REMARK LINK REVDAT 2 24-FEB-09 1OHE 1 VERSN REVDAT 1 24-JUL-03 1OHE 0 JRNL AUTH C.H.GRAY,V.M.GOOD,N.K.TONKS,D.BARFORD JRNL TITL THE STRUCTURE OF THE CELL CYCLE PROTEIN CDC14 REVEALS A JRNL TITL 2 PROLINE-DIRECTED PROTEIN PHOSPHATASE JRNL REF EMBO J. V. 22 3524 2003 JRNL REFN ISSN 0261-4189 JRNL PMID 12853468 JRNL DOI 10.1093/EMBOJ/CDG348 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1404031.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 17049 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900 REMARK 3 FREE R VALUE TEST SET COUNT : 998 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2537 REMARK 3 BIN R VALUE (WORKING SET) : 0.2630 REMARK 3 BIN FREE R VALUE : 0.3310 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2770 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.64000 REMARK 3 B22 (A**2) : 12.86000 REMARK 3 B33 (A**2) : -7.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.67000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.450 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.380 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.240 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.170 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.210 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 14.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARAM19X.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPH19X.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OHE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1290012790. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16051 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.33500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 8000, 0.1 M ZINC ACETATE PH REMARK 280 8.0, 20 OC HANGING DROP VAPOUR DIFFUSION, PH 8.00, VAPOR REMARK 280 DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.38000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.57500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.38000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.57500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 39 REMARK 465 ARG A 40 REMARK 465 ARG A 41 REMARK 465 GLN A 381 REMARK 465 GLU A 382 REMARK 465 ASN A 383 REMARK 465 GLY A 384 REMARK 465 GLN A 385 REMARK 465 HIS A 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 42 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 43 CG OD1 OD2 REMARK 470 TYR A 373 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 377 CG CD CE NZ REMARK 470 LYS A 379 CG CD CE NZ REMARK 470 GLY A 380 CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 216 CA - CB - CG ANGL. DEV. = 18.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 44 -3.56 -57.83 REMARK 500 TYR A 86 -111.61 -139.24 REMARK 500 ARG A 223 -42.29 -140.29 REMARK 500 ARG A 233 126.49 80.23 REMARK 500 SER A 314 -150.10 -137.45 REMARK 500 VAL A 352 102.27 65.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OHC RELATED DB: PDB REMARK 900 STRUCTURE OF THE PROLINE DIRECTED PHOSPHATASE CDC14 REMARK 900 RELATED ID: 1OHD RELATED DB: PDB REMARK 900 STRUCTURE OF CDC14 IN COMPLEX WITH TUNGSTATE DBREF 1OHE A 39 386 UNP O60729 O60729 39 386 DBREF 1OHE B 0 3 PDB 1OHE 1OHE 0 3 SEQADV 1OHE SER A 314 UNP O60729 CYS 314 CONFLICT SEQRES 1 A 348 PRO ARG ARG ARG ASP PRO GLN ASP ASP VAL TYR LEU ASP SEQRES 2 A 348 ILE THR ASP ARG LEU CYS PHE ALA ILE LEU TYR SER ARG SEQRES 3 A 348 PRO LYS SER ALA SER ASN VAL HIS TYR PHE SER ILE ASP SEQRES 4 A 348 ASN GLU LEU GLU TYR GLU ASN PHE TYR ALA ASP PHE GLY SEQRES 5 A 348 PRO LEU ASN LEU ALA MET VAL TYR ARG TYR CYS CYS LYS SEQRES 6 A 348 ILE ASN LYS LYS LEU LYS SER ILE THR MET LEU ARG LYS SEQRES 7 A 348 LYS ILE VAL HIS PHE THR GLY SER ASP GLN ARG LYS GLN SEQRES 8 A 348 ALA ASN ALA ALA PHE LEU VAL GLY CYS TYR MET VAL ILE SEQRES 9 A 348 TYR LEU GLY ARG THR PRO GLU GLU ALA TYR ARG ILE LEU SEQRES 10 A 348 ILE PHE GLY GLU THR SER TYR ILE PRO PHE ARG ASP ALA SEQRES 11 A 348 ALA TYR GLY SER CYS ASN PHE TYR ILE THR LEU LEU ASP SEQRES 12 A 348 CYS PHE HIS ALA VAL LYS LYS ALA MET GLN TYR GLY PHE SEQRES 13 A 348 LEU ASN PHE ASN SER PHE ASN LEU ASP GLU TYR GLU HIS SEQRES 14 A 348 TYR GLU LYS ALA GLU ASN GLY ASP LEU ASN TRP ILE ILE SEQRES 15 A 348 PRO ASP ARG PHE ILE ALA PHE CYS GLY PRO HIS SER ARG SEQRES 16 A 348 ALA ARG LEU GLU SER GLY TYR HIS GLN HIS SER PRO GLU SEQRES 17 A 348 THR TYR ILE GLN TYR PHE LYS ASN HIS ASN VAL THR THR SEQRES 18 A 348 ILE ILE ARG LEU ASN LYS ARG MET TYR ASP ALA LYS ARG SEQRES 19 A 348 PHE THR ASP ALA GLY PHE ASP HIS HIS ASP LEU PHE PHE SEQRES 20 A 348 ALA ASP GLY SER THR PRO THR ASP ALA ILE VAL LYS GLU SEQRES 21 A 348 PHE LEU ASP ILE CYS GLU ASN ALA GLU GLY ALA ILE ALA SEQRES 22 A 348 VAL HIS SER LYS ALA GLY LEU GLY ARG THR GLY THR LEU SEQRES 23 A 348 ILE ALA CYS TYR ILE MET LYS HIS TYR ARG MET THR ALA SEQRES 24 A 348 ALA GLU THR ILE ALA TRP VAL ARG ILE CYS ARG PRO GLY SEQRES 25 A 348 SER VAL ILE GLY PRO GLN GLN GLN PHE LEU VAL MET LYS SEQRES 26 A 348 GLN THR ASN LEU TRP LEU GLU GLY ASP TYR PHE ARG GLN SEQRES 27 A 348 LYS LEU LYS GLY GLN GLU ASN GLY GLN HIS SEQRES 1 B 4 ACE ALA SEP PRO MODRES 1OHE SEP B 2 SER PHOSPHOSERINE HET ACE B 0 3 HET SEP B 2 10 HETNAM ACE ACETYL GROUP HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 ACE C2 H4 O FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 HOH *143(H2 O) HELIX 1 1 ASP A 43 ASP A 47 5 5 HELIX 2 2 ASN A 93 SER A 110 1 18 HELIX 3 3 ILE A 111 LEU A 114 5 4 HELIX 4 4 ASP A 125 LEU A 144 1 20 HELIX 5 5 THR A 147 ILE A 156 1 10 HELIX 6 6 THR A 178 TYR A 192 1 15 HELIX 7 7 ASN A 201 LYS A 210 1 10 HELIX 8 8 ALA A 211 GLY A 214 5 4 HELIX 9 9 PRO A 245 HIS A 255 1 11 HELIX 10 10 ALA A 270 ASP A 275 1 6 HELIX 11 11 THR A 292 ASN A 305 1 14 HELIX 12 12 LEU A 318 ARG A 334 1 17 HELIX 13 13 THR A 336 ARG A 348 1 13 HELIX 14 14 GLY A 354 LEU A 378 1 25 SHEET 1 AA 4 VAL A 48 ASP A 51 0 SHEET 2 AA 4 LEU A 56 ILE A 60 -1 O PHE A 58 N LEU A 50 SHEET 3 AA 4 LYS A 117 THR A 122 1 O ILE A 118 N CYS A 57 SHEET 4 AA 4 VAL A 71 SER A 75 1 O HIS A 72 N VAL A 119 SHEET 1 AB 5 LEU A 216 ILE A 220 0 SHEET 2 AB 5 PHE A 224 PHE A 227 -1 O PHE A 224 N ILE A 219 SHEET 3 AB 5 ALA A 309 HIS A 313 1 O ILE A 310 N ILE A 225 SHEET 4 AB 5 VAL A 257 ARG A 262 1 N THR A 258 O ALA A 309 SHEET 5 AB 5 ASP A 279 ASP A 282 1 O ASP A 279 N ILE A 260 LINK C ACE B 0 N ALA B 1 1555 1555 1.33 LINK C ALA B 1 N SEP B 2 1555 1555 1.34 LINK C SEP B 2 N PRO B 3 1555 1555 1.35 CISPEP 1 GLY A 90 PRO A 91 0 0.10 CRYST1 114.760 53.150 64.170 90.00 117.48 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008714 0.000000 0.004532 0.00000 SCALE2 0.000000 0.018815 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017565 0.00000